Alamar Biosciences, Inc. (ALMR) is a Biotechnology company in the Healthcare sector, listed on Nasdaq. This page provides the complete earnings calendar, dividend schedule, and financial data for Alamar Biosciences, Inc. in 2026. The next earnings report is expected on December 2, 2026.
Next earnings date
02 Dec 2026
In 105 days
EPS estimate
-0.21
Revenue estimate
29.0M
Past earnings
Latest earnings analysis
Alamar Biosciences beat consensus estimates in its latest earnings report, with EPS of -$0.22 versus an estimate of -$0.3079 and revenue of $29.4 million, exceeding estimates by 13.7%. In the prior quarter, EPS missed expectations while revenue met estimates.
No dividend history available.
Alamar Biosciences operates as a commercial-stage proteomics firm, specializing in the highly sensitive, simultaneous identification of various proteins for both scientific research and prospective medical applications. Their integrated platform brings together proprietary instruments, specialized consumables, and unique software, forming a comprehensive, end-to-end solution. This system is designed for accurately quantifying multiple proteins, particularly those present in low concentrations, across a wide array of research and potential clinical uses.
Alamar Biosciences, Inc. (ALMR) is scheduled to report earnings on December 2, 2026.
Alamar Biosciences, Inc. (ALMR) last reported earnings on August 10, 2026.
Alamar Biosciences, Inc. (ALMR) is listed on Nasdaq.
We use cookies to make our website work and improve your experience. With your consent, we also use cookies for analytics and advertising.